Research ArticleCARDIOVASCULAR
A Comparison between Ranolazine and CVT-4325, a Novel Inhibitor of Fatty Acid Oxidation, on Cardiac Metabolism and Left Ventricular Function in Rat Isolated Perfused Heart during Ischemia and Reperfusion
Peipei Wang, Heather Fraser, Steven G. Lloyd, Jeffrey J. McVeigh, Luiz Belardinelli and John C. Chatham
Journal of Pharmacology and Experimental Therapeutics April 2007, 321 (1) 213-220; DOI: https://doi.org/10.1124/jpet.106.115519
Peipei Wang
Heather Fraser
Steven G. Lloyd
Jeffrey J. McVeigh
Luiz Belardinelli
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
A Comparison between Ranolazine and CVT-4325, a Novel Inhibitor of Fatty Acid Oxidation, on Cardiac Metabolism and Left Ventricular Function in Rat Isolated Perfused Heart during Ischemia and Reperfusion
Peipei Wang, Heather Fraser, Steven G. Lloyd, Jeffrey J. McVeigh, Luiz Belardinelli and John C. Chatham
Journal of Pharmacology and Experimental Therapeutics April 1, 2007, 321 (1) 213-220; DOI: https://doi.org/10.1124/jpet.106.115519
Research ArticleCARDIOVASCULAR
A Comparison between Ranolazine and CVT-4325, a Novel Inhibitor of Fatty Acid Oxidation, on Cardiac Metabolism and Left Ventricular Function in Rat Isolated Perfused Heart during Ischemia and Reperfusion
Peipei Wang, Heather Fraser, Steven G. Lloyd, Jeffrey J. McVeigh, Luiz Belardinelli and John C. Chatham
Journal of Pharmacology and Experimental Therapeutics April 1, 2007, 321 (1) 213-220; DOI: https://doi.org/10.1124/jpet.106.115519
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement